Search Results - Nikola Bangemann

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes

    Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes by Gerhard Schäller, Ilka Fuchs, Thomas Gonsch, Jan Weber, Anke Kleine-Tebbe, Peter Klare, Hans-Joachim Hindenburg, Volker Lakner, Axel Hinke, Nikola Bangemann

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy

    Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy by Petra Huehnchen, Christian Schinke, Nikola Bangemann, Adam Dordevic, Johannes S. Kern, Smilla K. Maierhof, Lois Hew, Luca Nolte, Peter Körtvélyessy, Jens Göpfert, Klemens Ruprecht, Christopher J. Somps, Jens‐Uwe Blohmer, Jalid Sehouli, Matthias Endres, Wolfgang Boehmerle

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions

    The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions by Berit Müller, E. Keil, Annika Lehmann, Klaus-Jürgen Winzer, Christiane Richter-Ehrenstein, Judith Prinzler, Nikola Bangemann, Angela Reles, Sylvia Stadie, Winfried Schoenegg, Jan Eucker, Marcus Schmidt, Frank Lippek, Korinna Jöhrens, Stefan Pahl, Bruno V. Sinn, Jan Budczies, Manfred Dietel, Carsten Denkert

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results

    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results by Oleg Gluz, Ulrike Nitz, Cornelia Liedtke, Matthias Christgen, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Nikola Bangemann, Christoph Lindner, Sherko Küemmel, Michael Clemens, Jochem Potenberg, Peter Staib, A. Kohls, Raquel von Schumann, Ronald Kates, Ronald Kates, Johannes Schumacher, Rachel Wuerstlein, Hans Kreipe, Nadia Harbeck

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: